$Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute gut graft-versus-host disease after pediatric allogeneic stem cell transplantation$

Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute gut graft-versus-host disease after pediatric allogeneic stem cell transplantation

Bibliographic Details
Main Authors:	Faizuddin Ansari, Neha Singh, Vikas Dua
Format:	Article
Language:	English
Published:	Elsevier 2017-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124517302358

Similar Items

Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study
by: Yamin Tan, et al.
Published: (2017-03-01)

Pediatric Haploidentical transplant: Single centre experience from North India
by: Neha Singh, et al.
Published: (2017-01-01)

Pneumatosis intestinalis in two pediatric patients after Haploidentical stem cell transplantation
by: Faizuddin Ansari, et al.
Published: (2017-01-01)

High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients
by: Faizuddin Ansari, et al.
Published: (2017-01-01)

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
by: Abedin S, et al.
Published: (2020-11-01)

Graft-versus-host diseases characterized by effusion: A case of steroid-refractory graft-versus-host disease
by: Osamu Imataki, et al.
Published: (2018-06-01)

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
by: Enrico Maffini, et al.
Published: (2016-08-01)

Extracorporeal Photopheresis for Steroid-refractory Chronic Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
by: Runzhe Chen, et al.
Published: (2015-01-01)

Two rare immunodeficiencies syndromes (Chediak Higashi Syndrome and Wiskott Aldrich Syndrome) cured successfully with haploidentical transplant
by: Neha Singh, et al.
Published: (2017-01-01)

Hematopoietic stem cell transplant (HSCT) in aplastic anemia (Acquired and Inherited): A single centre experience from North India
by: Neha Singh, et al.
Published: (2017-01-01)

Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease
by: Gursel Gunes, et al.
Published: (2015-01-01)

Fatal anaphylactic reaction due to Basiliximab
by: Patricia Lovisolo, et al.
Published: (2017-04-01)

Optimizing use of basiliximab in liver transplantation
by: Carlo B Ramirez, et al.
Published: (2010-01-01)

Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience.
by: Cornelis N De Jong, et al.
Published: (2017-01-01)

Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
by: Xiaomei Chen, et al.
Published: (2015-01-01)

Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation
by: T A Bykova, et al.
Published: (2013-08-01)

Anti-tumor necrosis factor-a for the treatment of steroid-refractory acute graft-versus-host disease
by: M.C. Nogueira, et al.
Published: (2007-12-01)

Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease
by: Dong Wang, et al.
Published: (2021-06-01)

Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons
by: Gabriel Tremblay, et al.
Published: (2021-02-01)

Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products
by: Makoto Murata, et al.
Published: (2021-08-01)

PHARMACOECONOMIC ANALYSIS OF DIFFERENT METHODS FOR THE TREATMENT OF STEROID-REFRACTORY GRAFT-VERUS-HOST DISEASE: SINGLE-CENTER STUDY
by: I. S. Moiseev, et al.
Published: (2018-03-01)

Meta-Analysis of Interleukin-2 Receptor Antagonists as the Treatment for Steroid-Refractory Acute Graft-Versus-Host Disease
by: Meng-Zhu Shen, et al.
Published: (2021-09-01)

Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation.
by: Jaak M Vossen, et al.
Published: (2014-01-01)

The role of basiliximab in the evolving renal transplantation immunosuppression protocol
by: Paola Salis, et al.
Published: (2008-06-01)

Basiliximab induction in renal transplantation: Long-term outcome
by: Mahendra Atlani, et al.
Published: (2013-01-01)

Treatment of refractory chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with low-dose interleukin-2
by: I. S. Moiseev, et al.
Published: (2015-12-01)

Treatment of Severe Steroid-Refractory Acute-Graft-vs.-Host Disease With Mesenchymal Stem Cells–Single Center Experience
by: Maja Česen Mazič, et al.
Published: (2018-07-01)

Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study
by: Xiaofei Qi, et al.
Published: (2018-09-01)

Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
by: Anna Cäcilia Ingham, et al.
Published: (2021-06-01)

Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation
by: Jacobo López-Abente, et al.
Published: (2021-01-01)

Mesenchymal Stem Cell Treatment for Steroid Refractory Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey
by: Fatih Erbey, et al.
Published: (2016-01-01)

Clinical-economic impact of the change of protocol for use of basiliximab in liver transplant
by: Enrique Tévar-Alfonso, et al.
Published: (2019-01-01)

Efficacy of basiliximab induction in poorly matched living donor renal transplantation
by: S Gundlapalli, et al.
Published: (2013-01-01)

Characterisation of host versus graft responses following allogeneic stem cell transplantation
by: Laylor, Ruthline Maria
Published: (2005)

IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice
by: Qingxiao Song, et al.
Published: (2021-02-01)

Etanercept on steroid-refractary acute graft-versus-host disease
by: Silvia González Munguía, et al.
Published: (2015-02-01)

Eculizumab treatment in a patient with hematopoietic stem cell transplantation-associated thrombotic microangiopathy and steroid-refractory acute graft versus host disease
by: Cristina Fernández, et al.
Published: (2015-12-01)

Graft-versus-leukemia and graft-versus-host: two sides of the immune effect of allogeneic stem cell transplantation
by: Sara Raquel Gonçalves Ribeiro
Published: (2021)

Thymic inoculation does not result in development of tolerance to allogeneic thyroid grafts in the outbred rabbit
by: Torchia, Mark G.
Published: (2007)

Thymic inoculation does not result in development of tolerance to allogeneic thyroid grafts in the outbred rabbit
by: Torchia, Mark G.
Published: (2007)

Cannot write session to /tmp/vufind_sessions/sess_p5eesv44mm3ubdpi66993ujbql